Analyst Gobind Singh works at HCWAINWRIGHT and is focused on the Healthcare sector with 22 price targets and ratings documented since 2021 spanning on 5 stocks. Analyst's average stock valuation to be materialised ratio is 4.17% with an average time for price targets to be met of 19 days.
Most recent stock forecast was given on PTGX, Protagonist Therapeutics, Inc at 14-Apr-2022.
Gobind Singh best performing recommendations are on PTGX (PROTAGONIST THERAPEUTICS, INC).
The best stock recommendation documented was for PTGX (PROTAGONIST THERAPEUTICS, INC) at 5/24/2021. The price target of $48 was fulfilled within 57 days with a profit of $12.69 (35.94%) receiving and performance score of 6.31.
Average potential price target upside
Currently, out of the existing stock ratings of Gobind Singh - 1609 which are a Buy (92.15%), 137 which are a Hold (7.85%)
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average time for PT to be met
Performance score
Hold
2
$1.83 (1076.47%)
4
1 months 16 days ago
3/5 (60%)
$2.08 (73.12%)
86
Hold
2
$1.83 (1076.47%)
5
4 months 15 days ago
4/5 (80%)
$1.51 (25.62%)
198
Buy
14
$13.83 (8135.29%)
18
1 years 6 months 3 days ago
2/4 (50%)
$3.36 (38.43%)
109
Buy
36
1 years 9 months 8 days ago
0/1 (0%)
$19.34 (116.09%)
Hold
13
$12.83 (7547.06%)
14
1 years 10 months 28 days ago
4/5 (80%)
$4.07 (43.59%)
73
